Viewing Study NCT01451632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-02-12 @ 1:50 AM
Study NCT ID: NCT01451632
Status: COMPLETED
Last Update Posted: 2016-09-08
First Post: 2011-10-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Sponsor: Merrimack Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Squamous Cell Head and Neck Cancer View
None Non-small Cell Lung Cancer View
None Triple Negative Breast Cancer View
None Other Tumors With EGFR Dependence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Colorectal cancer View
None Kras wild-type View
None Squamous cell head and neck cancer View
None Non-small cell lung cancer View
None Triple negative breast cancer View
None EGFR View
None ErbB3 View
None MM-121 View
None Cetuximab View
None Irinotecan View